Alternative short-term coverage costs less and lasts six to 12 months to fill in the gap between jobless and finding new employments.
The Senate has approved a $138 billion bill that would extend COBRA premium subsidies. Previous subsidies affected employees laid off from Sept. 1, 2008 through Feb. 28, 2010, and were recently extended to March 31. As written, the bill would extend the 65% federal COBRA subsidy through Dec. 31. It now heads to the House.
Without the subsidy, COBRA costs are more than unemployment benefits in some states, and would require the lion’s share of unemployment benefits in others. According to Families USA, a non-profit, non-partisan policy organization, the average unemployment benefit in the United States is $1,333 per month, while the average unsubsidized COBRA family coverage is $1,111 per month.
But there are alternatives to COBRA. While COBRA allows people to extend their former employers’ insurance plan for up to 18 months after employment was terminated, the former employee is responsible for the full premium. Alternative short-term coverage costs less and lasts six to 12 months to fill in the gap between jobless and finding new employment.
While the lower-costs plans don’t cover everything a COBRA plan would, more insurance providers are reaching out to the recently unemployed to provide them with options. One such provider is Cinergy Health, Sunrise, Fla., which has enlisted an ad agency.“With the help of this agency, we are able to identify the people we are reaching,” says Daniel Touizer, founder and CEO of Cinergy Health. “As customers call in, Cinergy Health addresses their individual needs and offers options.”While it may sound counterintuitive to focus sales efforts on the unemployed, Touzier says people are receptive to the right plan marketed in the right way.
“The reality is that with the current economic climate, household incomes are continuing to drop, and insurance prices are dramatically increasing,” he says. “Therefore, those looking to market insurance products must be sensitive to the present situation. Alternatives should be realistic and sensible, not just the same increased deductible plan that delivers a lower premium.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More